Anomaly Detection for Critical Care Risk Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current health risk assessment systems face challenges in accurately predicting adverse outcomes in critical care settings due to the sheer volume of patient data, high costs, and invasive collection processes, particularly for rare events where labeled training data is scarce.
Innovation Solution
The system employs anomaly detection methods like minimum enclosing ball (MEB), k-nearest neighbor (k-NN), and support vector machines (SVM) that do not require labeled data, allowing for unsupervised learning and effective prediction of adverse outcomes by identifying patients who differ significantly from the population, combined with multi-task learning to leverage both supervised and unsupervised learning methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional supervised learning methods are used for health risk assessment, then prediction accuracy can be improved with sufficient labeled training data, but data collection costs and complexity increase significantly
Solution Approach 1:
The patent extracts and utilizes only the essential features needed for anomaly detection from the complex patient data set, rather than requiring all traditional labeled training data. This reduces data collection complexity while maintaining prediction accuracy for adverse outcomes.
Solution Approach 2:
The patent replaces the mechanical supervised learning system (requiring labeled data collection, annotation, and training) with an unsupervised anomaly detection system that automatically identifies patterns without human-labeled training data, thereby reducing data collection complexity.
2Reliability
If comprehensive patient data is collected for accurate risk assessment, then prediction reliability improves, but healthcare costs and time consumption increase
Solution Approach 1:
The patent performs preliminary anomaly detection analysis on patient data without requiring time-consuming labeled training data collection. The system is pre-configured with anomaly detection algorithms that can immediately assess risk when new patient data arrives, reducing data collection time while maintaining reliability.
Solution Approach 2:
The anomaly detection system serves itself by automatically identifying patterns and anomalies in patient data without requiring external labeled training data or manual intervention for model training, thereby reducing both time and cost while maintaining prediction reliability.
3Adaptability or versatility
If traditional risk assessment models are used, then established prediction frameworks can be applied, but adaptability to rare adverse events is limited
Solution Approach 1:
Instead of trying to find rare adverse events in labeled training data (which loses information when data is scarce), the patent inverts the approach by detecting anomalies that deviate from normal patterns. This allows the system to adapt to rare events without requiring labeled training data for those specific rare conditions.
Solution Approach 2:
The patent changes the fundamental parameter of the detection approach from supervised classification (requiring labeled data) to unsupervised anomaly detection (requiring no labels). This parameter change enables the system to adapt to rare adverse events by detecting deviations from normal patient trajectories without needing labeled examples of those rare events.
4Measurement precision
If extensive labeled training data is collected for supervised learning, then model precision improves, but invasive and costly data collection processes are required
Solution Approach 1:
The patent extracts the essential predictive signal from patient data using anomaly detection algorithms that do not require invasive data collection. By focusing on detecting deviations from normal patterns rather than comprehensive labeled training, the system achieves precision while minimizing harmful invasive data collection.
Solution Approach 2:
The patent substitutes the invasive supervised learning mechanism (requiring comprehensive labeled data collection) with a non-invasive unsupervised anomaly detection mechanism that achieves similar or better precision by detecting patterns without requiring extensive patient data collection.
Data Source
AI summary
A method for assessing whether a patient is at risk of developing a clinical condition includes receiving training data representing a set of patient-related variables for each of a plurality of patients; generating model data based on the received training data; receiving target data representing the set of patient-related variables for a target patient; determining a risk level for the target patient of developing the clinical condition; and indicating the risk level of the target patient, where the set of patient-related variables consists of a first set of variables when the clinical condition is a mortality condition and a second set of variables when the clinical condition is a morbidity condition.